Product Images Aceon

This is a survival analysis table depicting the proportion of patients who had cardiovascular mortality, nonfatal myocardial infarction, or cardiac arrest over time (in years) for two groups of patients - one receiving a placebo and the other receiving perindopril. The Logrank p-value is reported as 0.0003, indicating a statistically significant difference in outcomes between the two groups. The number of patients at risk in each group is also provided for each time point.*

This is a medical document containing information about a female patient aged 58-65. The patient seemingly has no history of previous medical conditions such as hypertension, diabetes, or use of lipid-lowering and beta-blocker drugs. The document includes a table or chart showing the relative risk of perindopril versus a placebo, with squares representing the number of patients in each group.*

This text appears to be a product label or package insert for a medication containing 2mg of erbumine. The instructions advise to refer to accompanying literature for dosage and administration details, and to store the medication at a controlled room temperature of 2°-25°C (77°F). The product should be protected from moisture.*

Each tablet contains 87 perindopril erbumine. Dosage and administration information should be obtained from accompanying literature or product information. It should be stored at a controlled room temperature of 21025 (8 077D. It should be protected from moisture. Manufactured by Paheon Pharmaceuticals, Cincinnati, OH 45237, USA. Product of France. XOMA (US) LLC, Berkeley, CA 94710, USA. ACEON°® (perindopril erbumine) Tablets are available in 8mg and for prescription only.*